Edge Therapeutics, Inc. logo

Edge Therapeutics, Inc.

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and seeks to commercialize hospital-based therapies for acute life-threatening neurological and other conditions.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”EDGE” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.edgetherapeutics.com
Founded2009
Disease Focus
Development Stage
STOCK CODENASDAQ: EDGE
Address
300 Connell Drive, Suite 4000, NJ 07922
Berkeley Heights
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/edge-therapeutics-inc-” connections=”true” suffix=””]